297 patents currently held
18 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Aug 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
27
Ending by 2030
Aug 2027
Next term end
240
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Apr 2031 · High confidence
Also notable
Ends Apr 2034 · High confidence
Also notable
Ends Oct 2029 · High confidence
Allergen Desensitization Method
US 9,539,318
Cited by 33 later US patents, top 10% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
Wave Shaping Device, An Electronic Device, And A System
US 11,251,886
Cited by 13 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2034.
In Vitro Method for the Prognosis of Progression of a Cancer and of the Outcome in a Patient and Means for Performing Said Method
US 8,481,271
Cited by 37 later US patents, top 25% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Nov 21 to 28, 2026 · next Nov 21
- 11 fees due Dec 4 to 25, 2026 · next Dec 4
- 3 fees due Jan 4 to 23, 2027 · next Jan 4
- 5 fees due Feb 13 to 27, 2027 · next Feb 13
- 6 fees due Mar 5 to 22, 2027 · next Mar 5
- 2 fees due Apr 8 to 10, 2027 · next Apr 8
- 4 fees due May 5 to 21, 2027 · next May 5
- 4 fees due Jun 3 to 30, 2027 · next Jun 3
- 3 fees due Jul 2 to 26, 2027 · next Jul 2
- 2 fees due Aug 11 to 20, 2027 · next Aug 11
- 5 fees due Sep 5 to 29, 2027 · next Sep 5
- 6 fees due Oct 2 to 26, 2027 · next Oct 2
- 3 fees due Nov 3 to 12, 2027 · next Nov 3
Recent changes
- 7 of the patents on this record were granted since Aug 19, 2026
- 6 terms have ended since Aug 19, 2026
What they patent
The 5 largest of its 240 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Device for Assisting the Crawling of an Infant | 16 in force | to Sep 2042 |
| Allergen Desensitization Method | 7 in force | to Apr 2031 |
| Methods for the Treatment of Leber Congenital Amaurosis | 5 in force | to Jun 2032 |
| TET2 as a Diagnostic and Pronostic Marker in Hematopoietic Neoplasms | 4 in force | to May 2031 |
| Method for Clustering Nodes of a Textual Network Taking into Account Textual Content, Computer-Readable Storage Device and System Implementing Said Method | 3 in force | to Oct 2039 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,300,569 | In Vitro Method for the Prognosis of Progression of a Cancer and of the Outcome in a Patient and Means for Performing Said Method In force · Medium confidence | In force | Medium confidence | |
| US 8,674,044 | Immobilization of Membrane Proteins onto Supports via an Amphiphile In force · High confidence | In force | High confidence | |
| US 8,207,263 | Immobilization of Membrane Proteins onto Supports via an Amphiphile In force · High confidence | In force | High confidence | |
| US 8,102,328 | Method and Device for the Transmission of Waves In force · High confidence | In force | High confidence | |
| US 8,119,122 | Use of Gingival Fibroblasts for Vascular Cell Therapy In force · High confidence | In force | High confidence | |
| US 9,555,164 | Method for Preparing Porous Scaffold for Tissue Engineering In force · High confidence | In force | High confidence | |
| US 10,022,439 | Allergen Desensitization Method In force · High confidence | In force | High confidence | |
| US 10,272,151 | Allergen Desensitization Method In force · High confidence | In force | High confidence | |
| US 10,758,610 | Allergen Desensitization Method In force · High confidence | In force | High confidence | |
| US 11,202,826 | Allergen Desensitization Method In force · High confidence | In force | High confidence |
Also on record, not counted in the 297: 18 patents in force now held by others · 65 patents ended · 289 applications pending · 146 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.